Myosin Therapeutics Awarded Florida Cancer Innovation Fund Grant to Support STAR-GBM Clinical Trial (Myosin News)
UF startup Myosin Therapeutics has been awarded $2 million in funding from the Florida Department of Health through the Casey DeSantis Florida Cancer Innovation Fund to support the company’s STAR-GBM Phase 1/2 clinical trial evaluating MT-125 in patients newly diagnosed with glioblastoma.
INZECTO Awarded Pest Control Products Development Company of the Year 2026 (Environmental Business Review)
UF startup INZECTO has been awarded the Pest Control Products Development Company of the Year 2026 by Environmental Business Review.
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial (Globe Newswire)
Solid Biosciences Inc., which acquired UF startup AavantiBio, reported updated positive interim data from the ongoing Phase 1/2 INSPIRE DUCHENNE clinical trial of SGT-003.
Solid Biosciences Announces Oversubscribed $240 Million Private Placement (Globe Newswire)
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors for an approximately $240 million private placement.
LightPath Technologies Receives $9.6 Million Purchase Order for Cooled Infrared Cameras From Existing Defense Customer (PR Newswire)
UF startup LightPath Technologies, Inc., announced that it has secured a $9.6 million purchase order for cooled infrared cameras from an existing defense customer for use in defense and security applications, with deliveries expected throughout calendar year 2026.
Solid Biosciences Announces Positive Feedback From Type C Meeting With FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy (Globe Newswire)
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced a positive regulatory update from its recent Type C meeting with the U.S. FDA that supports the continued advancement of SGT-003 as a potential treatment for Duchenne muscular dystrophy.
Myosin Therapeutics Invited To Present at Biocom California’s Global Partnering & Investor Conference (PR Newswire)
UF startup Myosin Therapeutics has been selected to present at Biocom California’s Global Partnering & Investor Conference. Company leadership will share progress and engage with investors and strategic partners, highlighting continued momentum in advancing its therapeutic pipeline.
LightPath Technologies Acquires Amorphous Materials, Inc. (PR Newswire)
UF startup LightPath Technologies, Inc. announced it has acquired the assets of Amorphous Materials, Inc., which is an industrial manufacturer with complementary Chalcogenide glass melting technologies.
Genezen and Atsena Therapeutics Announce Strategic Commercial Manufacturing Partnership (PR Newswire)
UF startup Atsena Therapeutics and Genezen announced a manufacturing partnership to support the clinical development and future production of Atsena’s gene therapies for inherited retinal diseases.
Neuropacs Closes Seed Round of Financing (Businesswire)
UF startup neuropacs™ Corp. announced the successful raise of over $1.0 million in early-stage capital.